Investor Presentation Full Year 2021
40
Investor presentation Full year 2021
The total branded diabetes market has a global value of DKK
~300 billion annually
DKK
billion
400
Global diabetes market
DKK
The USA
+4%
billion
150
141 144
2020/2021 2019/2020 ☐ Growth at CER
-11%
+22%
100
+7%
64
52
55
-15%
302 295
44
+15%
50
300
16 20
17 16
0
Total
Insulin
GLP-1
DPP-IV
SGLT-2
200
DKK
Outside the USA
-3%
+8%
billion
125
117
+26%
161 151
150
+3%
90
-5%
100
75
+23%
+0%
53 59
100
73 73
+37%
+32%
42
36
37 39
50
26 20
25 19
0
Total
0
Insulin
GLP-1
DPP-IV
SGLT-2
Total
Insulin
GLP-1
DPP-IV
SGLT-2
Source: Company announcements as of Q3 2021; 2020/2021 data based on Q4 2020 to Q3 2021 and 2019/2020 data based on Q4 2019 to Q3 2020
Note: The segment value is based on reported figures, whilst the market growth is under constant exchange rate (CER). For Novo Nordisk the diabetes growth includes Insulin and GLP-1, excluding 'other diabetes care'.
Novo NordiskⓇView entire presentation